S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
3 Dividend Stocks to Help You Sleep Well at Night
Plug Power Stock is Recharging for Another Run
Time to Buy Pilgrim’s Pride Stock
A Square Stock Deal Is Emerging
Stocks fall as yields continue to climb; GameStop surges
Ribbon Communications (NASDAQ: RBBN) Stock Providing Pullback Opportunities
Tech rout pulls Nasdaq down 3.5%, biggest loss since October
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
3 Dividend Stocks to Help You Sleep Well at Night
Plug Power Stock is Recharging for Another Run
Time to Buy Pilgrim’s Pride Stock
A Square Stock Deal Is Emerging
Stocks fall as yields continue to climb; GameStop surges
Ribbon Communications (NASDAQ: RBBN) Stock Providing Pullback Opportunities
Tech rout pulls Nasdaq down 3.5%, biggest loss since October
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
3 Dividend Stocks to Help You Sleep Well at Night
Plug Power Stock is Recharging for Another Run
Time to Buy Pilgrim’s Pride Stock
A Square Stock Deal Is Emerging
Stocks fall as yields continue to climb; GameStop surges
Ribbon Communications (NASDAQ: RBBN) Stock Providing Pullback Opportunities
Tech rout pulls Nasdaq down 3.5%, biggest loss since October
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
3 Dividend Stocks to Help You Sleep Well at Night
Plug Power Stock is Recharging for Another Run
Time to Buy Pilgrim’s Pride Stock
A Square Stock Deal Is Emerging
Stocks fall as yields continue to climb; GameStop surges
Ribbon Communications (NASDAQ: RBBN) Stock Providing Pullback Opportunities
Tech rout pulls Nasdaq down 3.5%, biggest loss since October
Log in
LON:SENS

Sensyne Health Share Forecast, Price & News

GBX 165
0.00 (0.00 %)
(As of 02/25/2021 12:00 AM ET)
Add
Compare
Today's Range
163
Now: GBX 165▼
169
50-Day Range
117
MA: GBX 154.45▼
185
52-Week Range
26.10
Now: GBX 165▼
190
Volume23,399 shs
Average Volume428,644 shs
Market Capitalization£262.49 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care's ‘Initial Code of Conduct for data-driven health and care technology'.
Sensyne Health logo

Headlines

Sensyne Health Interim Loss Widens But Boasts Of Commercial Progress
January 21, 2021 |  lse.co.uk
Companies Like Sensyne Health (LON:SENS) Are In A Position To Invest In Growth
January 19, 2021 |  finance.yahoo.com
Sensyne Health Launches First Digital Health Product in the U.S.
December 15, 2020 |  finance.yahoo.com
Did Sensyne Health's (LON:SENS) Share Price Deserve to Gain 68%?
December 2, 2020 |  finance.yahoo.com
Sensyne Health appoints President, North America, to lead US expansion
November 13, 2020 |  finance.yahoo.com
Sensyne Health signs research collaboration deal with Bristol Myers Squibb
October 23, 2020 |  lse.co.uk
SMALL CAP SHARE IDEAS: Woodford's AI health darling Sensyne 'makes significant progress' as it provides software for coronavirus drug trial
October 5, 2020 |  msn.com
Do Insiders Own Lots Of Shares In Sensyne Health plc (LON:SENS)?
September 16, 2020 |  finance.yahoo.com
Sensyne Health announces the UK launch of ‘SENSETM’ - a clinical algorithm engine, created in partnership with Microsoft
September 3, 2020 |  finance.yahoo.com
Analysts optimistic on Sensyne Health outlook
August 24, 2020 |  uk.finance.yahoo.com
Sensyne Health PLC (SSYNF)
August 17, 2020 |  nasdaq.com
The Global mHealth Market size is expected to reach $206.1 billion by 2026, rising at a market growth of 31.6% CAGR during the forecast period
May 15, 2020 |  uk.finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange LON
Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolLON:SENS
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.sensynehealth.com
Phone44 3300 581845
Employees70
Year FoundedN/A

Debt

Debt-to-Equity Ratio6.83
Current Ratio3.71
Quick Ratio3.71

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales£3.98 million
Price / Sales66.02
Cash FlowGBX 14.23 per share
Price / Cash Flow11.60
Book ValueGBX 23.70 per share
Price / Book6.96

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares159,085,000
Market Cap£262.49 million
Next Earnings DateN/A
OptionableOptionable

MarketRank™

Overall MarketRank™

1.50 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
GBX 165
0.00 (0.00 %)
(As of 02/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sensyne Health (LON:SENS) Frequently Asked Questions

Is Sensyne Health a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sensyne Health in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Sensyne Health stock.
View analyst ratings for Sensyne Health or view top-rated stocks.

What stocks does MarketBeat like better than Sensyne Health?

Wall Street analysts have given Sensyne Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sensyne Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Sensyne Health's stock been impacted by COVID-19 (Coronavirus)?

Sensyne Health's stock was trading at GBX 39 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SENS stock has increased by 323.1% and is now trading at GBX 165.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for SENS?

2 brokerages have issued 12 month price targets for Sensyne Health's stock. Their forecasts range from GBX 310 to GBX 310. On average, they expect Sensyne Health's stock price to reach GBX 310 in the next year. This suggests a possible upside of 87.9% from the stock's current price.
View analysts' price targets for Sensyne Health or view top-rated stocks among Wall Street analysts.

Who are some of Sensyne Health's key competitors?

Some companies that are related to Sensyne Health include Craneware (CRW), kneat.com, inc. (KSI.V) (KSI), Vitalhub (VHI), Reliq Health Technologies (RHT), Induction Healthcare Group PLC (INHC.L) (INHC), IQ-AI Limited (IQAI.L) (IQAI), DIAGNOS (ADK), CardioComm Solutions (EKG), 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), CloudMD Software & Services (DOC) and CloudMD Software & Services (DOCRF).
View all of SENS's competitors.

What other stocks do shareholders of Sensyne Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensyne Health investors own include Fresenius Medical Care AG & Co. KGaA (FME), Green Plains Partners (GPP), The Hershey (HSY), Gilead Sciences (GILD), Griffon (GFF), Emerald (EEX), DHX Media (DHXM), Ctrip.Com International (CTRP), Corus Entertainment (CJR) and Citizens Financial Group (CFG).

What is Sensyne Health's stock symbol?

Sensyne Health trades on the London Stock Exchange (LON) under the ticker symbol "SENS."

How do I buy shares of Sensyne Health?

Shares of SENS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Sensyne Health's stock price today?

One share of SENS stock can currently be purchased for approximately GBX 165.

How much money does Sensyne Health make?

Sensyne Health has a market capitalization of £262.49 million and generates £3.98 million in revenue each year.

How many employees does Sensyne Health have?

Sensyne Health employs 70 workers across the globe.

What is Sensyne Health's official website?

The official website for Sensyne Health is www.sensynehealth.com.

How can I contact Sensyne Health?

The company can be reached via phone at 44 3300 581845.


This page was last updated on 2/26/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.